ARTICLE | Clinical News
Ozurdex dexamethasone intravitreal implant regulatory update
September 15, 2014 7:00 AM UTC
Allergan said the European Commission expanded the label of Ozurdex dexamethasone intravitreal implant to include treatment of visual impairment due to diabetic macular edema (DME) in adults who are p...